Please login to the form below
Financials
This page shows the latest Financials news and features for those working in and with pharma, biotech and healthcare.
Novartis first to benefit from NICE advice on ‘patient preference’
In the last financial year, NICE Scientific Advice generated £1.8m, income which makes a modest contribution to sustaining the agency, which has seen its funding cut back and its workload
Latest news
-
A genomics and digital-led NHS is possible – but investment in staff essential
However, there are also concerns that the scale of the cultural challenge, and the level of financial investment required to bring about these changes won’t be forthcoming.
-
Analysts look beyond Keytruda in Merck’s future
MSD’s chief financial officer Rob Davis said on the call that spending on R&D would rise faster than sales growth for the next couple of years as the Keytruda
-
UK patient activist group takes aim at Orkambi patent
Vertex refused the largest ever financial offer the NHS has made in its entire history for this medicine,” Wiggin told The Guardian newspaper, which has thrown its weight behind the crown
-
Ashfield partners with MIMS, WA Health wins new account and Lighthouse relocates
Lucid’s US-based company Lighthouse Medical Communications has moved to new offices based in the financial district of Manhattan, New York.
-
Hardy returns to Genentech as CEO
He also insisted that the decision is completely unrelated to its financial and business performance, with Q4 results expected to be announced on 5 February.
More from news
Approximately 72 fully matching, plus 1,627 partially matching documents found.
Latest Intelligence
-
The UK’s new five-year pricing agreement
Industry agrees to contribute to NHS financial sustainability through an overall cap on growth on NHS-branded medicines sales at a nominal rate of 2% per year, with member companies making ... Routes to market. A single, shared approach to horizon-
-
How industry platforms can help transform outcomes-based contracting in healthcare
what health outcomes are being achieved and their financial implications.
-
The handover: Pfizer reshapes itself for a new era
Pfizer’s chief financial officer and executive vice president, global supply and business operations, Frank D’Amelio, will assume the leadership of its manufacturing operations, Pfizer Global Supply.
-
Brexit: can pharma 'take back control' of the narrative?
All of this means that the NHS could become increasingly distracted by financial and staffing challenges, and unable to focus on transforming care and driving up patient outcomes. .
-
Tackling a formidable foe
All will be fighting for reimbursement across a squeezed financial landscape so good trial data alone may not be a clear route to authorisation.
More from intelligence
Approximately 1 fully matching, plus 207 partially matching documents found.
Latest appointments
-
BMS appoints new commercial leader, Davies joins Eisai and more
There, Britten will take responsibility for all financial aspects of the business and will play a key role in business development. ... She brings financial leadership and business development expertise, as we move forward commercially on the back of our
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more
Most recently, he held the position of managing director at Raymond James Financial. ... capital and financial markets. “His deep industry expertise, experience in oncology and connectivity within the U.S.
-
Pharma industry appointments
Rodgers, who has gained board experience in both public and private growth companies, has a background in the financial sector as a corporate financier and investment banker. ... His career history has seen him serve as interim chief financial officer
-
Healthcare comms appointments
Both Ubhi and Rehman joins Lucid’s financial team and Knight becomes the group’s interim head of facilities.
-
Weekly industry appointments
Allen, who has also served as chief financial officer of Celltech Group, said: “I am looking forward to taking on the role of chairman and am delighted to have the opportunity
More from appointments
Approximately 0 fully matching, plus 212 partially matching documents found.
Latest from PMHub
-
Obesity Management Market is Poised to Reach US$ 1,078.9 by 2027
High costs involved in the research &development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions.
-
Clinical Trials Market : Dynamics, Segments, Size and Demand, 2015 - 2025
product, United States Food and Drug (FDA) form 1572, protocol and amendments, inform consent, other written information for participants, recruitment advertisement, financial disclosure form (FDF), master clinical trial agreement (MCTA),
-
Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK
Based on 2017 financial data that was compiled and analysed in November 2018, the MRS league tables identify and rank the best-performing research agencies and businesses according to their
-
HSJ Partnership Awards 2019 shortlist announced
Value Awards. Excellence in procurement, financial management and driving value helps the NHS serve patients.
-
Random42 attending Biotech Showcase in San Francisco
The event, held at the Hilton San Francisco Union Square, brings more than 3, 600 decision makers from 2, 200 biotech, financial, and pharma companies to network and share insights on
More from PMHub
Approximately 0 fully matching, plus 98 partially matching documents found.
Featured jobs
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- Lighthouse Medical Commuications US appoints Lisa Druce as its new Managing Partner
- GW Pharma's cannabis-based medicine to be tested in dementia
- International Childhood Cancer Day 2019
- AZ says dropping MedImmune will help ‘streamline’ its R&D
- Merck puts prostate cancer firmly in Keytruda’s sights
- Biosimilar Herceptin helps Roche gain new Perjeta recommendation
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- International Childhood Cancer Day 2019
- The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
- Immuno-oncology in 2019: the rapid evolution continues
- Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
- Mixing up Focus Groups
- A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...
Quick links
Infographics
